Tradelines News

Get the latest news and updates on cross-border customs and international trade.

Health Canada Requests Quarantine of Products for Canadian Market from Apotex Facility in Bangalore,

Posted September 29, 2014

Under Canadian Customs Issues, International Trade Issues

(Health Canada)

At Health Canada’s request, Apotex Inc. will quarantine products for the Canadian market manufactured at the Apotex Research Private Limited (ARPL) facility in Bangalore, India, based on a recent import ban of products from that facility by the U.S. Food and Drug Administration (FDA).

Health Canada is gathering more information, including the reasons for the FDA’s actions and the potential impact of any issues it has identified on products for the Canadian market. The quarantine will allow the Department time to verify that products from this facility meet Canadian safety and quality requirements. Read more here.